A Review of Different Analytical Techniques for Fexofenadine Hydrochloride and Montelukast Sodium in Different Matrices

References

• United State Department of Health and Human Services. Environmental Allergies: Symptoms, National Institute of Allergy and Infectious Diseases. https://www.cdc.gov/healthcommunication/toolstemplates/entertainmented/tips/Allergies.html. 2015 (accessed July 29, 2019).
   Google Scholar
• United State. Department of Health and Human Services. Food Allergy- An Overview, National Institute of Allergy and Infectious Diseases. https://www.niaid.nih.gov/diseases-conditions/food-allergy. 2011 (accessed July 29, 2019).
   Google Scholar
• Bahna, S. L. Cow’s Milk Allergy versus Cow Milk Intolerance. Ann. Allergy Asthma Immunol. 2002, 89, 56–60. DOI: 10.1016/S1081-1206(10)62124-2.
   PubMed Web of Science ®Google Scholar
• Connell, M.; Thomas, H. The Nature of Disease: Pathology for the Health Professions. Baltimore, MD: Lippincott Williams and Wilkins, 2007
   Google Scholar
• Borriello, F.; Iannone, R.; Marone, G. Histamine Release from Mast Cells and Basophils. HandbExp. Pharmacol. 2017, 24, 121–139.
   Google Scholar
• Asthma Fact sheet N 307, World Health Organization. https://www.who.int/news-room/fact-sheets/detail/asthma, 2011 (accessed July 29, 2019).
   Google Scholar
• Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, National Asthma Education and Prevention Program, National Heart, Lung and Blood Institute. https://www.nhlbi.nih.gov/files/docs/resources/lung/NHLBAC-Asthma-WG-Report, 2007 (accessed July 30, 2019).
   Google Scholar
• Holgate, S. T.; Polosa, R. Treatment Strategies for Allergy and Asthma. Nat. Rev. Immunol. 2008, 8, 218–230. DOI: 10.1038/nri2262.
   PubMed Web of Science ®Google Scholar
• Salvi, S. S.; Krishna, M. T.; Sampson, A. P.; Holgate, S. T. The anti-Inflammatory Effects of Leukotriene-Modifying Drugs and Their Use in Asthma. Chest 2001, 119, 1533–1546. DOI: 10.1378/chest.119.5.1533.
   PubMed Web of Science ®Google Scholar
• Bachert, C. A Review of the Efficacy of Desloratadine, Fexofenadine, and Levocetrizine in the Treatment of Nasal Congestion in Patients with Allergic Rhinitis. Clin. Ther. 2009, 31, 921–944. DOI: 10.1016/j.clinthera.2009.05.017.
   PubMed Web of Science ®Google Scholar
• Compalati, E.; Baena-Cagnani, R.; Penagos, M.; Badellino, H.; Braido, F.; Gomez, R. M.; Canonica, G. W.; Baena Cagnani, C. E. Systematic Review on the Efficacy of Fexofenadine in Seasonal Allergic Rhinitis: A Meta Analysis of Randomized, Double-Blind, Placebo-Controlled Clinical Trials. Int. Arch. Allergy Immunol. 2011, 156, 1–15. DOI: 10.1159/000321896.
   PubMed Web of Science ®Google Scholar
• Montvale N. J.; Thomson P. D. R. (60th Eds). The Physicians’ Desk Reference; Florence, 2006, pp 2857–5858.
   Google Scholar
• Prescribing Information. Allegra (Fexofenadine); Sanofi-Avenis: Bridgewater, NJ, 2007. https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20872se8-003,20625se8-010_allegra (accessed July 12, 2019).
   Google Scholar
• Van Cauwenberge, P.; Juniper, E. F. Star Study Investigating Group. Comparsion of the Efficacy, Safety and Quality of Life Provided by Fexofenadine 120mg, Loratadine 10mg, and Placebo Administered Once Daily for the Treatment of Seasonal Allergic Rhinitits. Clin. Exp. Allergy 2000, 30, 891–899. DOI: 10.1046/j.1365-2222.2000.00914.x.
   PubMed Web of Science ®Google Scholar
• Howarth, P.; Stern, M.; Roi, L.; Reynolds, R.; Bousquet, J. Double-Blind, Placebo Controlled Study Comparing the Efficacy and Safety of Fexofenadine Hydrochloride(120 and 180mg Once Daily) and Cetirizine in Seasonal Allergic Rhinitis. J. Allergy Clin. Immunol. 1999, 104, 927–923. DOI: 10.1016/S0091-6749(99)70070-9.
   PubMed Web of Science ®Google Scholar
• Gross, G. N.; Ganster, K.; Meeves, S.; Liao, Y.; Geroge, G. C. A Double-Blind, Randomized Comparsion of Fexofenadine 180mg versus Cetrizine 10mg: Effect on Instantaneous Symptom Score at the 24th Hour. Ann. Allergy Asthma Immunol. 2003, 20, 125.
   Google Scholar
• Lippert, C.; Ling, J.; Brown, P.; Burmaster, S.; Eller, M.; Cheng, L. Mass Balance and Pharmacokinetics of MDL 16, 455A in Healthy Male Volunteers. Pharma. Res. 1995, 12, 390.
   Google Scholar
• Markham, A.; Wagstaff, A. J. Fexofenadine. Drugs 1998, 55, 269–276. DOI: 10.2165/00003495-199855020-00012.
   PubMed Web of Science ®Google Scholar
• Garteiz, D. A.; Hook, R. H.; Walker, B. J.; Okerholm, R. A. Pharmacokinetics and Biotransformation Studies of Terfenadine in Man. Arzneimittelforschung 1982, 32, 1185–1190.
   PubMed Web of Science ®Google Scholar
• Martindale: The Complete Drug Reference, 36th ed.; Pharma Press: London, 2009, pp 1126–1127.
   Google Scholar
• Scott, J. P.; Peters-Golden, M. Antileukotriene Agents for the Treatment of Lung Diseases. Am. J. Respir. Crit. Care Med. 2013, 188, 538–544. DOI: 10.1164/rccm.201301-0023PP.
   PubMed Web of Science ®Google Scholar
• Garg, L. L.; Ravi Kumar, B.; Krishnamurthy, T. Shakil Suliaman Sait. Determination of Montelukast Sodium in Oral Granules Dosage Forms by Simple and Accurate UV Spectrophotometric Methods. Int. J. Pharma. Sci Rev. Res. 2011, 7, 69–72.
   Google Scholar
• Kumar Pandey, A.; Dwivedi, D. Titrimetric Assay of Some Antihistamine with Pyridinium Fluoro Chromate(PFC) Reagent. J. Drug Delivery Ther. 2018, 8, 407–410. DOI: 10.22270/jddt.v8i5.1947.
   Google Scholar
• Rele Rajan, V.; Sawant Swapnil, A. A Validated Non-Aqueous Potentiometric Titration Method for Quantitative Determination of Fexofenadine Form Pharmaceutical Preparation. J. Chem. Pharm. Res. 2013, 5, 286–289.
   Google Scholar
• Aslan, N.; Erden, P. E.; Canel, E.; Kilic, E. Development and Validation of a Potentiometric Titration Method for the Determination of Montelukast Sodium in a Pharmaceutical Preparation and Its Protonation Constant. Bulgar Chem. Commun. 2014, 46, 497–502.
   Google Scholar
• Colkesen, B.; Oztiik, F.; Erden, P. E. Electroanalytical Characterization of Montelukast Sodium and Its Voltammetric Determination in Pharmaceutical Dosage Form and Biological Fluids. J. Braz. Chem. Soc. 2016, 27, 849–856.
   Web of Science ®Google Scholar
• Ashour, S.; Khateeb, M.; Mahrouesh, R. Extractive Spectrophotometric and Conductometric Methods for Determination of Fexofenadine Hydrochloride in Pharmaceutical Dosage Forms. Pharm. Anal. Acta 2013, 82, 01–06. DOI: 10.4172/2153-2435.S2-003.
   Google Scholar
• Herrmann, R.; Onkelinx, C. Quantities and Units in Clinical Chemistry: Nebulizer and Flame Properties in Flame Emission and Absorption Spectrometry. Pure Appl. Chem. 1986, 58, 1737–1742. DOI: 10.1351/pac198658121737.
   Web of Science ®Google Scholar
• Narayana, B.; Veena, K. A New Method for the Spectrophotometric Determination of Fexofenadine Hydrochloride. Indian J. Chem. Technol. 2010, 17, 386–390.
   Web of Science ®Google Scholar
• Polawar, P. V.; Shivhare, U. D.; Bhusari, K. P.; Mathur, V. B. Development and Validation of Spectrophotometric Method of Analysis for Fexofenadine HCl. RG J. Pharm. Technol. 2008, 1, 539–554.
   Google Scholar
• Suresh Kumar, K.; Ravichandran, V.; Mohan Maruga Raja, M. K.; Thyagu, R.; Dharamsi, A. Spectrophotometric Determination of Fexofenadine Hydrochloride. Indian J. Pharm. Sci. 2011, 73, 300–302. DOI: 10.4103/0250-474X.31034.
   PubMed Web of Science ®Google Scholar
• Shanmukha Kumar, J. V.; Ramachandran, D.; Sushma, K.; Vijaya Saradhi, S. UV-Visible Spectrophotometric Methods for Estimation of Montelukast Sodium in Bulk Dosage Forms and Formulations. Orient. J. Chem. 2010, 26, 293–296.
   Google Scholar
• Raghubabu, K.; Sanadhyarani, K. Assay of Fexofenadine Hydrochloride in Pharmaceutical Preparation by Visible Spectrophotometry. Der Pharma Chem. 2014, 6, 436–439.
   Google Scholar
• Raghu, M. S.; Shantharam, C. S.; Yogesh Kumar, K. Application of Bromate-Bromide Mixture as a Green Brominating Agent for the Determination of Fexofenadine Hydrochloride Pharmaceutical Dosage Form. J. Anal. Pharm. Res. 2018, 7, 13–21.
   Google Scholar
• Breier, A. R.; Steppe, M.; Schapoval, E. E. S. Validation of UV Spectrophotometric Method for Fexofenadine Hydrochloride in Pharmaceutical Formulations and Comparison with HPLC. Anal. Lett. 2007, 40, 2329–2327. DOI: 10.1080/00032710701576023.
   Web of Science ®Google Scholar
• Dobariya Chandrika, T.; Bhumika Patel, R.; Zarna Dedania, R.; Vijendraswamy, S. M. UV Spectrophotometric Method Development and Validation for Fexofenadine Hydrochloride in Bulk and Tablet Dosage Form. J. Pharma Res. 2015, 4, 63–68.
   Google Scholar
• Singh, K.; Bagga, P.; Shakya, P.; Kumar, A.; Khalid, M.; Akhtar, J.; Arif, M. Validated UV Spectroscopic Method for Estimation of Montelukast Sodium. Int. J. Pharm. Sci. Res. 2015, 6, 4728–4732.
   Web of Science ®Google Scholar
• Chaudhary, M.; Kumar, P.; Thapliyal, D. Analytical Method Development and Validation for Determination of Montelukast by UV-Spectroscopy in API and in Pharmaceutical Dosage Forms. Int. J. Pharm. Bio. Sci. 2018, 4, 482–487.
   Google Scholar
• Pallavi, K.; Srinivasa Babu, P. Validated UV Spectroscopic Method for Estimation of Montelukast Sodium from Bulk and Tablet Formulations. Int. J. Ad. Pharm. Bio. Chem. 2012, 1, 450–452.
   Google Scholar
• Sowjanya, G.; Trideva Sastri, K. UV Spectrophotometric Method Development and Validation for Simultaneous Determination of Fexofenadine Hydrochloride and Montelukast Sodium in Tablets. World J. Pharm. Pharm. Sci. 2017, 6, 780–789.
   Google Scholar
• Lata Kothapalli, P.; Atul Mahajan, G. B.; Asha Thomas, B.; Rabindra Nanda, K.; Narnaware, S. Simultaneous Spectrophotometric Estimation of Fexofenadine Hydrochloride and Montelukast Sodium in Pharmaceutical Dosage Form. Int. J. Institution Pharm. Life Sci. 2012, 2, 72–80.
   Google Scholar
• Patle, D.; Nagar, S. UV Visible Spectrophotometric Method for Estimation of Montelukast and Fexofenadine by Simultaneous Equation Method in Bulk and Combined Dosage Form. Curr. Trends Biotech. Pharm. 2017, 11, 382–388.
   Google Scholar
• Vekaria, H. J.; Muralikrsihna, K. S.; Patel, G. F. Development and Validation of Spectrophotometric Method for Estimation of Fexofenadine Hydrochloride and Montelukast Sodium in Combined Dosage Form, Inventi Impact. Pharm. Anal. Qual. Assur. 2011, 15, 1–8.
   Google Scholar
• Kozan, I.; Murat Palabiyik, I.; Karacan, E.; Onur, F. Spectrophotometric and High Performance Liquid Chromatographic Determination of Fexofenadine Hydrochloride in Pharmaceutical Formulations. Turk. J. Pharm. Sci. 2008, 5, 175–189.
   Google Scholar
• Arvind Sakalgaonkar, A.; Sunil Mirgane, R.; Pawar, R. P. Validated LC Method, with a Chiral Mobile Phase, for Separation of the Isomers of Fexofenadine Hydrochloride. Chromatographia 2008, 68, 143–146. DOI: 10.1365/s10337-008-0667-6.
   Web of Science ®Google Scholar
• Swarnalatha, G.; Vijayakumar, B.; Jothieswari, D.; Poojitha, M.; Ravi Chandrakumar, A.; Gobala Krishnan, P. RP-HPLC Method Development and Validation for Simultaneous Estimation of Montelukast Sodium and Fexofenadine HCl in a Pharmaceutical Dosage Form. Int. J. Med. Chem. Anal. 2016, 6, 44–51.
   Google Scholar
• Alothman, Z. A.; Bukhari, N.; Haider, S.; Wabaidur, S. M.; Alwarthan, A. A. Saikh Mohammad Wabaidur, Abdulrahamn Alwarhan, A. Spectrofluorimeric Determination of Fexofenadine Hydrochloride in Pharmaceutical Preparation Using Silver Nanoparticles. Arabian J. Chem. 2010, 3, 251–255. DOI: 10.1016/j.arabjc.2010.06.008.
   Web of Science ®Google Scholar
• Alsarra, I.; Khalil, N. Y.; Sultan, M.; Al-Ashban, R.; Belal, F. Spectrofluorometric Determination of Montelukast in dosage forms and spiked human plasma. Pharmazie 2005, 60, 823–826.
   PubMed Web of Science ®Google Scholar
• Al-Kindy, M. Z.; Salma, K. A.-S.; Fakhr Eldin Suliman, O.; Haidar Ai-Lawati, A. J. Terbium Sensitized Luminescence for the Determination of Fexofenadine in Pharmaceutical Formulations. Arabian J. Chem. 2015, 5, 1–7.
   Google Scholar
• Redondo, J.; Capdevila, A.; Ciudad, S. Determination of the Enantiomeric purity of the Antiasthmatic Drug Montelukast by Means of 1H NMR Spectroscopy. Chirality 2013, 25, 780–786. DOI: 10.1002/chir.22213.
   PubMed Web of Science ®Google Scholar
• Cuatrecasas, P.; Wilchek, M.; Anfinsen, C. B. Selective Enzyme Purification by Affinity Chromatography. Proc. Natl. Acad. Sci. USA. 1968, 61, 636–643. DOI: 10.1073/pnas.61.2.636.
   PubMed Web of Science ®Google Scholar
• Porath, J. From Gel Filtration to Adsorptive Size Exclusion. J. Protein Chem. 1997, 16, 463–468. DOI: 10.1023/A:1026357326667.
   PubMedGoogle Scholar
• Laurence Harwood, M.; Christopher Moody, J. Experimental Organic Chemistry: Principle and Pratice. Wiley John & Sons: UK, 1989, pp 180–185.
   Google Scholar
• Sutar, P. M.; Bansode, D. A.; Dhaneshwar, S. S. Stability Indicating Thin-Layer Chromatographic Determination of Fexofenadine Hydrochloride as Bulk Drug: Application to Forced Degradation Study. Der Pharma. Sin. 2015, 6, 30–39.
   Google Scholar
• Athavia, B. A.; Dedania, Z. R.; Dedania, R. R.; Vijayendra Swamy, S. M.; Chandrika, D.,T. Stability Indicating HPTLC Method Development for Fexofenadine Hydrochloride. Eur. J. Biomed. Pharm. Sci. 2017, 4, 697–705.
   Google Scholar
• Pallavi Sutar, M.; Deepali Bansode, A.; Suneela Dhaneshwar, S. Development and Validation of HPTLC Method for Analysis of Fexofenadine Hydrochloride s a Bulk Drug and in Tablet Dosage Form. World J. Pharm. Res. 2015, 4, 1757–1769.
   Google Scholar
• Vekaria, H.; Muralikrishna, K. S. Mandip Sorathiya, Development and Validation of HPTLC Method for Simultaneous Estimation of Montelukast Sodium and Fexofenadine Hydrochloride in Combined Dosage Form. Der Pharmacia Lettre. 2011, 4, 755–762.
   Google Scholar
• Suparna Tandulwadkar, S.; Sehal More, J.; Atul Rathore, S.; Nikam, A.; Lohidasan Sathiyanarayanan, R.; Kakasaheb Mahadik, R. Method Development and Validation for the Simultaneous Determination of Fexofenadine Hydrochloride and Montelukast Sodium in Drug Formulation Using Normal Phase High-Performance Thin-Layer Chromatography. ISRN Anal. Chem. 2012, 56, 1–7. DOI: 10.5402/2012/924185.
   Google Scholar
• Hadir Maher, M.; Maha Sultan, A.; Ileana Olah, V. Development of Validated Stability-Indicating Chromatographic Method for the Determination of Fexofenadine Hydrochloride and Its Related Impurities in Pharmaceutical Tablets. Chem. Central J. 2011, 5, 10. DOI: 10.1186/1752-153X-5-76.
   PubMedGoogle Scholar
• Nimje, H. M.; Shital Nimje, T.; Oswal, R. J.; Bhamre, S. T. Stability Indicating RP-HPLC Method for Estimation of Fexofenadine Hydrochloride in Pharmaceutical Formulation. E- J. Chem. 2012, 9, 1257–1265. DOI: 10.1155/2012/394945.
   Google Scholar
• Patnaik, A.; Panda, S. S.; Sahoo, S.; Patro, V. J. RP-HPLC Method Development and Validation for the Determination and Stability Indicative Studies of Montelukast in Bulk and Its Pharmaceutical Formulations. E- J. Chem. 2012, 9, 35–42. DOI: 10.1155/2012/692424.
   Google Scholar
• Roman, J.; Breier, A. R.; Steppe, M. Stability Indicating LC Method to Determination of Sodium Montelukast in Pharmaceutical Dosage Form and Its Photo Degradation Kinetics. J. Chromatogr. Sci. 2011, 49, 540–546. DOI: 10.1093/chrsci/49.7.540.
   PubMed Web of Science ®Google Scholar
• Eldin, A. I. B.; Shalaby, A.; El-Tohamy, M. Development and Validation of a HPLC Method for the Determination of Montelukast and Its Degradation Products in Pharmaceutical Formulation Using an Experimental Design. Acta Pharm. Sciencia. 2010, 53, 45–56.
   Google Scholar
• Thummisetty, M.; Sama, J. R.; Surya Narayana Rao, V.; Reddanna, P. Stability Indicating Assay Method for Montelukast Sodium in Pharmaceutical Formulations by RP-HPLC. J. Pharm. Sci. Res. 2011, 3, 1373–1377.
   Google Scholar
• Kumar, G. V.; Rajesh, T.; Chandra, J. A Stability Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Montelukast Sodium and Fexofenadine Hydrochloride in Bulk and Pharmaceutical Dosage Form. Indo Am. J. P. Sci. 2018, 5, 16756–16765.
   Web of Science ®Google Scholar
• Rameezuddin, M. D.; Vasanth, P. M.; Ramesh, T.; Ramesh, M. Method Development and Stability Indicating RP-HPLC Method for the Estimation of Montelukast and Fexofenadine for Bulk and Pharmaceutical Dosage Form. Int. J. Chem. Tech. Res. 2013, 5, 2821–2829.
   Google Scholar
• Rajeev Kumar, P.; Kumar, R. R. Validated Stability-Indicating Isocratic RP-HPLC Method of Estimation of Montelukast Sodium and Fexofenadine Hydrochloride in Bulk and in Solid Dosage by Vierodt’s Method. J. Chem. Pharm. Res. 2017, 9, 297–243.
   Google Scholar
• Pankhaniya, M.; Patel, P.; Shah, J. S. Stability-Indicating HPLC Method for Simultaneous Determination of Montelukast and Fexofenadine Hydrochloride. Indian J. Pharm. Sci. 2013, 75, 284–290. DOI: 10.4103/0250-474X.117426.
   PubMed Web of Science ®Google Scholar
• Padmavaathi, K.; Subba Rao, M. A New Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Fexofenadine Hydrochloride and Montelukast in Combined Dosage Form. Der Pharmacia Lettre 2015, 7, 301–307.
   Google Scholar
• Oliveria, D. C.; Weich, A.; Rolim, M. B. Simple and Reliable HPLC Analysis of Fexofenadine Hydrochloride in Tablets and Its Application to Dissolution Studies. Pharmazie 2007, 62, 96–100.
   PubMed Web of Science ®Google Scholar
• Breier, A. R.; Paim, C. S.; Steppe, M.; Schapoval, E. E. S. Development and Validation of Dissoluion Tests for Fexofenadine Hydrochloride Capsules and Coated Tablets. J. Pharm. Pharm. Sci. 2005, 8, 289–298.
   PubMed Web of Science ®Google Scholar
• Malothu, N.; Paladugu, T.; Katamaneni, P. Development and Validation of RP-HPLC Method for Determination of Fexofenadine in Pharmaceutical Dosage Form by Using Levocetirizine as an Internal Standard. Int. J. Pharm. Biol. Sci. 2018, 8, 619–625.
   Google Scholar
• Rajan Rele, V. Determination of Fexofenadine Hydrochloride in Pharmaceutical Dosage Form by Reverse Phase High Performance Liquid Chromatography Method. Der Pharmacia Lettre 2016, 8, 224–228.
   Google Scholar
• Barabde, G. R.; Ambadekar, S. R.; Nishad, A. Comparative Study of Estimation of Fexofenadine Hydrochloride by UV-Visible Spectrophotometry and HPLC Method. J. Res. Pharm. Sci. 2016, 2, 01–04.
   Google Scholar
• Wang, D.; Zhou, C.; Cong, R.; Li, Y.; Wang, X. Simultaneous Determination of Montelukast Sodium S-Enantiomer and A5 Enantiomers in Montelukast Sodium Bulk Drug by Normal-Phase Chiral HPLC. Indian J. Pharm. Sci. 2017, 79, 139–148.
   Web of Science ®Google Scholar
• Singh, R. M.; Saini, P. K.; Mathur, S. C.; Singh, G. N.; Lal, B. Development and Validation of a RP-HPLC Method for Estimation of Montelukast Sodium in Bulk and in Tablet Dosage Form. Indian J. Pharm. Sci. 2010, 72, 235–237. DOI: 10.4103/0250-474X.65023.
   PubMed Web of Science ®Google Scholar
• Kanakadurga Devi, N.; Prameela Rani, A.; Madhavi, B. R.; Mrudula, B. S. New RP-HPLC Method for the Analysis of Montelukast Sodium in Pharmaceutical Dosage Forms. Int. J. Chem. Tech. Res. 2010, 2, 471–475.
   Google Scholar
• Dipti Phadtare, G.; Amol Pawar, R.; Rajashri Kulkarni, R.; Govind Patil, K. Method Development and Validation of Montelukast Sodium in Bulk and Tablet Dosage Formulation by HPLC. Asia. J. Res. Chem. 2016, 9, 339–342. DOI: 10.5958/0974-4150.2016.00051.1.
   Google Scholar
• Muralidharan, S.; Jia Qi, L.; Ting Yi, L.; Kaur, N.; Parasuraman, S.; Kumar, J.; Venugopal, V.; Vasanth Raj, P. Newly Developed and Validated Method of Montelukast Sodium Estimation in Tablet Dosage Form by Ultraviolet Spectroscopy and Reverse Phase-High Performance Liquid Chromatography, Pharmacology. PTB Rep. 2016, 2, 27–30. DOI: 10.5530/PTB.2016.2.2.
   Google Scholar
• Priyanka, S.,D.; Akiful Haque, M.; Harshini, S.; Baskshi, V. Method Development and Validation of Fexofenadine Hydrochloride and Montelukast Sodium in a Combined Dosage Form by RP-HPLC Method. Int. J. Med. Nanotechnol. 2014, 1, 174–178.
   Google Scholar
• Tamilselvi, N.; Sruthi, K. Development of Validated HPLC Method for Simultaneous Estimation of Fexofenadine Hydrochloride and Montelukast Sodium in Tablet Dosage Form. Int. J. Pharm. Sci. Res. 2012, 3, 4876–4881.
   Google Scholar
• Manasa, Y. L.; Srinivasa Rao, N.; Regalla, M. R. Method Development and Validation for Simultaneous Estimation of Fexofenadine HCl and Montelukast Sodium by RP-HPLC in Pure and Combined Tablet Dosage Form. World J. Pharm. Pharm. Sci. 2013, 2, 5948–5965.
   Google Scholar
• Ravisankar, M.; Uthirapathy, S.; Thangadurai, A.; Munusamy, J.; Dhanapal, K. Simultaneous Estimation of Fexofendine Hydrochloride and Montelukast Sodium in Bulk and Marketed Formulation by RP-HPLC Method. Int. Res. J. Pharm. 2014, 3, 356–359.
   Google Scholar
• Kalyankar Tukaram, M.; Wale Risha, R.; Kakde Rajendra, B. Development and Validation of RP-HPLC Method for Estimation of Montelukast Sodium and Fexofenadine Hydrochloride in Pharmaceutical Preparations. Chem. Sci. Trans. 2013, 2, 889–899. DOI: 10.7598/cst2013.361.
   Google Scholar
• Tushar Kakade, C.; Atul Rathore, S.; Lqhidasan, S.; Kakasaheb Mahadik, R. Separation and Determination of Fexofenadine Hydrochloride and Montelukast Sodium in Tablet Dosage Form Using RP-HPLC. Anveshana Int. J. Res. Pharm. Life Sci. 2016, 1, 54–65.
   Google Scholar
• Vekaria, H.; Limbasiya, V.; Patel, P. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Montelukast Sodium and Fexofenadine Hydrochloride in Combined Dosage Form. J. Pharm. Res. 2013, 6, 134–139. DOI: 10.1016/j.jopr.2012.11.028.
   Google Scholar
• Chabukswar Anirudha, R.; Choudhari Vishnu, P.; Jagdale Swati, C.; Sharma Shialesh, N.; Bari Nilesh, A. Pagare Bharat D. Simultaneous Estimation of Montelukast Sodium and Fexofenadine HCl in Pharmaceutical Formulation by RP-LC-PDA. Int. J. Pharm. Sci. Res. 2012, 3, 241–248.
   Google Scholar
• Nagaraju, P.; Vishnu Manasa, G.; Indira Priyadarshini, G.; Appaji, S. S. Development and Validation of Novel RP-HPLC Method for Simultaneous Estimation of Fexofenadine Hydrochloride and Montelukast Sodium in Pharmaceutical Dosage Forms. Int. J. Pharm. Chem. Sci. 2013, 2, 2017–2023.
   Google Scholar
• Godavarthi, M.; Sujana, K.; Pramila Rani, A. Method Development and Validation for the Simultaneous Determination of Fexofenadine Hydrochloride and Montelukast Sodium Using RP-HPLC. ISRN Anal. Chem. 2012, 2, 41–48. DOI: 10.9790/3013-25404148.
   Google Scholar
• Prashanth Kumar, K.; Akiful Haque, M.; Pradeep Kumar, T.; Nivedita, G.; Hasan Amrohi, S.; Prasad, V. V. L. N.; Prakash, V. D. Simultaneous Determination of Montelukast Sodium and Fexofenadine Hydrochloride in Combined Dosage Form by Using RP-HPLC Method. World J. Chem. 2012, 7, 42–46.
   Google Scholar
• Saeed Arayne, M.; Sultana, N.; Shehnaz, H.; Haider, A. RP-HPLC Method for the Quantitative Determination of Fexofenadine Hydrochloride in Coated Tablets and Human Serum. Med. Chem. Res. 2011, 20, 55–61. DOI: 10.1007/s00044-009-9285-6.
   Web of Science ®Google Scholar
• Uno, T.; Yasui-Furukori, N.; Takahata, T.; Sugawara, K.; Tateishi, T. Liquid Chromatographic Determination of Fexofenadine in Human Plasma with Fluorescence Detection. J. Pharm. Biomed. Anal. 2010, 4, 937–942. DOI: 10.1016/j.jpba.2004.02.036.
   Google Scholar
• Ai-Rawithi, S.; Ai-Gazian, S.; Ai-Ahmadi, W.; Ai Aishowaier Yusuf, A.; Raines, D. A. Expedient Liquid Chromatographic Method with Fluorescence Detection for Montelukast Sodium in Micro-Samples of Plasma. J. Chromatogr. B Biomed. Sci. Appl. 2001, 2, 527–531. DOI: 10.1016/S0378-4347(01)00025-1.
   Google Scholar
• Smith, G. A.; Rawls, C. M.; Kunka, R. L. An Automated Method for the Determination of Montelukast in Human Plasma Using Dual-Column HPLC Analysis and Peak Height Summation of the Parent Compound and Its Photo Degradation Product. Pharm. Res. 2004, 21, 1539–1544. DOI: 10.1023/B:PHAM.0000041445.76931.27.
   PubMed Web of Science ®Google Scholar
• Ochiai, H.; Uchiyama, N.; Takano, T.; Hara, K.; Kamei, T. Determination of Montelukast Sodium in Human Plasma by Column-Switching High Performance Liquid Chromatography with Fluorescence Detection. J. Chromatogr. B Biomed. Sci. Appl. 1998, 13, 409–414. DOI: 10.1016/S0378-4347(98)00179-0.
   Google Scholar
• Liu, L.; Cheng, H.; Zhao, J. J.; Rogers, J. D. Determination of Montelukast(MK-0476) and Its S-Enantiomer in Human Plasma by Stereoselective High-Performance Liquid Chromatography with Column-Switching. J. Pharm. Biomed. Anal. 1997, 15, 631–638. DOI: 10.1016/S0731-7085(96)01894-8.
   PubMed Web of Science ®Google Scholar
• Vaghela, B.; Singh Rao, S.; Reddy, A. M.; Venkatesh, P.; Kumar, N. Identification and Characterization of an Oxidative Degradation Product of Fexofenadine, Development and Validation of a Stability-Indicating RP-UPLC Method for the Estimation of Process Related Impurities and Degradation Products of Fexofenadine in Pharmaceutical Formulations. Sci. Pharm. 2012, 80, 295–309. DOI: 10.3797/scipharm.1111-07.
   PubMedGoogle Scholar
• Kuna, M.; Sankar Dannana, G. Stability-Indicating UPLC Method for Estimation of Montelukast and Fexofenadine Simultaneously in the Presence of Stress Degradation Products. J. Global Trends Pharm Sci. 2017, 8, 4542–4553.
   Google Scholar
• Mustafa, M.; Amuthalakshmi, S.; Nalini, C. N. Simultaneous UPLC Estimation of Fexofenadine HCl and Montelukast Sodium in Tablet Dosage Form. Res. J. Pharm. Technol. 2017, 19, 10.
   Google Scholar
• Stanton, M. L.; Joy, M. S.; Frye, R. F. Validation and Application of a Liquid Chromatography-Tandem Mass Spectrometric Method for Quantification of the Drug Transport Probe Fexofenadine in Human Plasma Using 96-Well Filter Plates. J. Chromatogr. B. 2010, 878, 1–11.
   PubMed Web of Science ®Google Scholar
• Hofmann, U.; Seller, M.; Drescher, S.; Fromm, M. F. Determination of Fexofenadine in Human Plasma and Urine by Liquid Chromatography-Mass Spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2002, 766, 227–233. DOI: 10.1016/S0378-4347(01)00468-6.
   PubMed Web of Science ®Google Scholar
• Kumar Veeragoni, A.; Sindgi, V. M.; Satla, S. R. Bioanalytical Method Validation of Montelukast Salt in Human Plasma Using LC-MS/MS Method. Der Pharma Chem. 2016, 8, 6–16.
   Google Scholar
• Ezzeldin, E.; Tammam, M. H.; AboTalib, N. F. Development of an LC-Tandem Mass Spectrometry Method for the Separation of Montelukast and Its Application to a Pharmacokinetic Study in Humans. Drug Res. (Stuttg) 2014, 64, 617–622. DOI: 10.1055/s-0034-1366986.
   PubMedGoogle Scholar
• Challa, B. R.; Awen, B. Z.; Rao Chandu, B.; Khagga, M.; Kotthapalli, C. B. Method Development and Validation of Montelukast in Human Plasma by HPLC Coupled with ESI-MS/MS: Application to a Bioequivalence Study. Sci. Pharm. 2010, 78, 411–422. DOI: 10.3797/scipharm.1002-07.
   PubMedGoogle Scholar
• Papp, R.; Luk, P.; Mullett, W. M.; Kwong, E. A Rapid and Sensitive Method for the Quantitation of Montelukast in Sheep Plasma Using Liquid Chromatography/Tandem Mass Spectrometry. J. Chromatogr. B. 2007, 858, 282–286. DOI: 10.1016/j.jchromb.2007.08.003.
   PubMed Web of Science ®Google Scholar
• Patel, N. K.; Subbaiah, G.; Shah, H.; Kundlik, M.; Sanyal, M.; Shrivastav, P. S. Rapid Determination of Montelukast in Human Plasma by LC-SI-MS/MS and Its Applicaion to a Bioequivalence Study. J. Anal. Lett. 2009, 42, 2041–2059. DOI: 10.1080/00032710903082721.
   Web of Science ®Google Scholar
• Gunasakaran, S.; Rao, N.; Arunkumar, S.; Olaganathan, A. A Rapid and Sensitive Method for the Quantitation of Montelukast in Human Plasma Using Liquid Chromatography/Tandem Mass Spectrometer. Int. J. Pharm. Sci. Res. 2010, 1, 65–72.
   Google Scholar
• Jo, M.-H.; Park, M.-S.; Seo, J.-H.; Shim, W.-S.; Yim, S.-V.; Lee, K.-T. Pharmacokinetic Analysis of Montelukast in Healthy Korean Volunteers by High Performance Liquid Chromatography-Tandem Mass Spectrometry. J. Pharm. Invest. 2011, 5, 289–294. DOI: 10.4333/KPS.2011.41.5.289.
   Google Scholar
• Mikus, P.; Valaskova, I.; Havranek, E. Determination of Fexofenadine in Tablets by Capillary Electrophoresis in Free Solution and in Solution with Cyclodextrins as analyte carriers. Drug Dev. Ind. Pharm. 2005, 31, 795–801. DOI: 10.1080/03639040500217368.
   PubMed Web of Science ®Google Scholar
• Roman, J.; Malesuik, M. D.; Jablonski, A.; Steppe, M. Stability Indicating Method for Sodium Montelukast in Pharmaceutical Preparation by Micellar Electrokinetic Capillary Chromatography. Int. J. Pharm. Sci. 2010, 6, 645–649.
   Google Scholar